Gossamer Bio GOSS
NASDAQ GOSS
$9.46 -0.33 (-3.37%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Price to Sales (2024 - 2026)

Updated

Gossamer Bio's (GOSS) Price to Sales was 0.99 for Q2 2026, down 85.7% from 6.95 a year earlier and down 28.7% from the prior quarter.

Analysis

Gossamer Bio (GOSS) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Gossamer Bio was 14.94, up 735.9% from FY2024.

  • By year, Price to Sales came in at 1.79 in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly Price to Sales in data going back to Q2 2024.
  • Year over year, Price to Sales gained in three of the last five quarters, with growth averaging 279.4%.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 1.39 (Q1 2026), 14.94 (Q4 2025) and 13.81 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Gossamer Bio 37.12 Mn -436.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.99
Mar 31, 2026 1.39
Dec 31, 2025 14.94
Sep 30, 2025 13.81
Jun 30, 2025 6.95
Mar 31, 2025 2.01
Dec 31, 2024 1.79
Sep 30, 2024 2.12
Jun 30, 2024 2.13
API Access

Gossamer Bio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=GOSS&period=max&api_key=YOUR_API_KEY